Skip to main content

West Pharmaceutical Services balance sheet

  • WST · NYSE
  • Medical devices
  • Health Care Supplies
  • S&P 500
$416.42+1.24%Close 13 Nov 2026

At the end of fiscal 2025 (the year to 31 Dec 2025), West Pharmaceutical Services reported total assets of $4.27B, $791.3M in cash and equivalents, $321.1M of total debt; shareholders' equity was $3.18B.

From West Pharmaceutical Services's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025.

Annual

West Pharmaceutical Services balance sheet, annual
USDFY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Cash and equivalents$87.20M$83.10M$110.2M$91.80M$161.9M$230.0M$255.3M$274.6M$203.0M$235.9M$337.4M$439.1M$615.5M$762.6M$894.3M$853.9M$484.6M$791.3M
Short-term investments——$600.0K$26.50M$12.40M$7.50M————————————
Cash and short-term investments$87.20M$83.10M$110.8M$118.3M$174.3M$237.5M$255.3M$274.6M$203.0M$235.9M$337.4M$439.1M$615.5M$762.6M$894.3M$853.9M$484.6M$791.3M
Accounts receivable—$138.7M$126.4M$147.2M$175.0M$185.7M$179.0M$181.4M$200.5M$253.2M$288.2M$319.3M$385.3M$489.0M$507.4M$512.0M$552.5M$574.4M
Inventory—$129.2M$147.0M$151.8M$162.2M$176.9M$181.5M$181.1M$199.3M$215.2M$214.5M$235.7M$321.3M$378.4M$414.8M$434.7M$377.0M$443.9M
Current assets—$397.2M$436.6M$472.0M$557.3M$650.7M$659.1M$673.7M$641.9M$743.5M$894.4M$1.06B$1.37B$1.74B$1.92B$1.94B$1.54B$1.98B
Property, plant and equipment—$577.1M$554.8M$593.6M$669.0M$711.7M$705.8M$721.0M$778.3M$855.0M$822.0M$839.3M$943.2M$1.06B$1.16B$1.41B$1.58B$1.73B
Goodwill—$114.2M$112.5M$111.5M$112.5M$114.2M$108.6M$104.6M$103.0M$107.7M$105.8M$107.8M$111.1M$109.9M$107.3M$108.5M$106.0M$109.9M
Acquired intangibles—$55.60M$55.10M$52.00M$50.60M$48.30M$42.00M$37.60M$23.30M$21.70M$20.30M$29.80M$30.50M$23.00M$18.40M$15.10M$10.80M$7.70M
Total assets—$1.27B$1.29B$1.40B$1.56B$1.67B$1.67B$1.70B$1.72B$1.86B$1.98B$2.34B$2.79B$3.31B$3.62B$3.83B$3.64B$4.27B
Accounts payable—$68.40M$63.20M$89.80M$102.9M$108.0M$103.1M$119.8M$122.0M$138.1M$130.4M$156.8M$213.1M$232.2M$215.4M$242.4M$239.3M$253.7M
Unearned revenue, current—————$1.50M$1.50M$1.50M$1.50M$1.50M$25.50M$27.50M$51.00M$48.70M$57.30M$41.70M$49.60M$51.90M
Long-term debt · current portion—$500.0K$300.0K$50.10M$32.70M$2.20M$27.20M$69.30M$2.40M$0.00$100.0K$2.30M$2.30M$44.20M$2.20M$134.0M$0.00$0.00
Current liabilities—$171.1M$169.7M$243.2M$261.8M$236.9M$252.5M$314.3M$241.0M$279.5M$283.7M$341.6M$503.4M$594.1M$519.0M$671.8M$550.4M$654.9M
Long-term debt · non-current—$379.1M$358.1M$299.3M$378.8M$371.3M$308.3M$228.9M$226.2M$197.0M$196.0M$255.0M$252.9M$208.8M$206.7M$72.80M$202.6M$202.8M
Operating lease liability———————————$72.00M$70.50M$72.30M$109.0M$102.2M$99.70M$118.3M
Finance lease liability———————————$0.00$0.00$0.00$0.00—$3.00M$5.10M
Total liabilities—$691.9M$668.6M$744.2M$835.1M$765.2M$712.8M$671.2M$599.2M$582.9M$582.6M$768.2M$939.3M$978.4M$931.9M$948.5M$961.1M$1.09B
Retained earnings—$569.4M$612.6M$664.5M$719.9M$805.0M$902.2M$964.6M$1.07B$1.18B$1.35B$1.55B$1.85B$2.46B$2.99B$3.52B$3.96B$4.37B
Shareholders' equity$487.1M$579.1M$625.7M$654.9M$728.9M$906.4M$956.9M$1.02B$1.12B$1.28B$1.40B$1.57B$1.85B$2.34B$2.68B$2.88B$2.68B$3.18B
Total liabilities and equity—$1.27B$1.29B$1.40B$1.56B$1.67B$1.67B$1.70B$1.72B$1.86B$1.98B$2.34B$2.79B$3.31B$3.62B$3.83B$3.64B$4.27B
Total debt—$379.6M$358.4M$349.4M$411.5M$373.5M$335.5M$298.2M$228.6M$197.0M$196.1M$329.3M$325.7M$325.3M$317.9M$309.0M$302.3M$321.1M
Net debt—$296.5M$247.6M$231.1M$237.2M$136.0M$80.20M$23.60M$25.60M−$38.90M−$141.3M−$109.8M−$289.8M−$437.3M−$576.4M−$544.9M−$182.3M−$470.2M
Net working capital—$143.0M$156.7M$137.0M$133.6M$183.8M$151.3M$84.80M$197.9M$228.1M$273.3M$278.0M$254.8M$385.3M$506.2M$410.7M$503.1M$532.0M
Shares outstanding · period end—66.0M66.6M67.4M68.6M70.2M71.3M72.3M73.1M73.9M74.1M74.1M74.0M74.2M74.1M73.5M72.3M72.0M

Quarterly

West Pharmaceutical Services balance sheet, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Cash and equivalents$853.9M$601.8M$446.2M$490.9M$484.6M$404.2M$509.7M$628.5M$791.3M$521.4M$435.8M$464.1M
Cash and short-term investments$853.9M$601.8M$446.2M$490.9M$484.6M$404.2M$509.7M$628.5M$791.3M$521.4M$435.8M$464.1M
Accounts receivable$512.0M$524.0M$479.4M$524.3M$552.5M$543.6M$582.4M$625.0M$574.4M$685.6M$712.0M$748.2M
Inventory$434.7M$429.9M$419.2M$401.2M$377.0M$388.7M$421.1M$438.0M$443.9M$452.6M$447.4M$464.7M
Current assets$1.94B$1.69B$1.48B$1.55B$1.54B$1.46B$1.68B$1.82B$1.98B$1.83B$1.81B$1.82B
Property, plant and equipment$1.41B$1.45B$1.49B$1.57B$1.58B$1.63B$1.72B$1.74B$1.73B$1.70B$1.69B$1.67B
Goodwill$108.5M$107.6M$107.3M$108.8M$106.0M$107.5M$110.9M$110.6M$109.9M$109.2M$108.7M$108.7M
Acquired intangibles$15.10M$13.90M$12.90M$12.30M$10.80M$10.00M$9.70M$8.90M$7.70M$7.00M$6.40M$6.20M
Total assets$3.83B$3.60B$3.49B$3.68B$3.64B$3.62B$3.95B$4.11B$4.27B$4.11B$4.08B$4.06B
Accounts payable$242.4M$240.1M$211.7M$224.3M$239.3M$228.4M$239.0M$255.8M$253.7M$252.3M$252.7M$249.4M
Unearned revenue, current$41.70M———$49.60M———$51.90M———
Long-term debt · current portion$134.0M$133.4M$132.9M$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Current liabilities$671.8M$648.4M$633.7M$516.5M$550.4M$526.7M$604.6M$635.4M$654.9M$674.0M$640.5M$644.3M
Long-term debt · non-current$72.80M$72.80M$72.90M$202.6M$202.6M$202.6M$202.6M$202.7M$202.8M$202.8M$202.9M$202.9M
Operating lease liability$102.2M$100.4M$104.9M$102.2M$99.70M$100.6M$100.7M$94.90M$118.3M$113.4M$109.2M$102.1M
Finance lease liability——$3.30M$3.10M$3.00M$4.20M$4.90M$5.40M$5.10M$4.80M$4.40M$8.90M
Total liabilities$948.5M$921.7M$912.6M$923.0M$961.1M$935.1M$1.02B$1.05B$1.09B$1.12B$1.09B$1.09B
Retained earnings$3.52B$3.62B$3.72B$3.86B$3.96B$4.03B$4.14B$4.26B$4.37B$4.48B$4.62B$4.82B
Shareholders' equity$2.88B$2.68B$2.58B$2.75B$2.68B$2.68B$2.93B$3.05B$3.18B$2.99B$2.99B$2.97B
Total liabilities and equity$3.83B$3.60B$3.49B$3.68B$3.64B$3.62B$3.95B$4.11B$4.27B$4.11B$4.08B$4.06B
Total debt$309.0M$306.6M$310.7M$304.8M$302.3M$303.2M$303.3M$297.6M$321.1M$316.2M$312.1M$305.0M
Net debt−$544.9M−$295.2M−$135.5M−$186.1M−$182.3M−$101.0M−$206.4M−$330.9M−$470.2M−$205.2M−$123.7M−$159.1M
Net working capital$410.7M$442.7M$403.1M$543.2M$503.1M$526.6M$566.6M$559.4M$532.0M$631.4M$731.2M$708.1M
Shares outstanding · period end73.5M73.0M72.6M72.5M72.3M71.8M71.9M71.9M72.0M70.9M70.4M69.8M

The main figures as JSON and plain text. See data and methodology.

WST in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.